| 2005P-0406 | Benzphetamine Hydrochloride Capsule, 50 mg drug product is suitable for submission as an ANDA | |||||||||||||||||||||||
| FDA Comment Number : | EC1 | |||||||||||||||||||||||
| Submitter : | Mr. Dave Lowe | Date & Time: | 02/01/2006 01:02:17 | |||||||||||||||||||||
| Organization : | Mr. Dave Lowe | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| 10/26/1960 is the approval date for Didrex. Didrex needs a new owner since owned by Pharmicia and Upjohn. Pfizer I suspect has no patent again.
NDA no. 012427 has never had clinical investigations as this was approved prior to legislation mandating efficacy be demonstrated. Remove Didrex, and all products which reference it from the market for efficacy reasons. | ||||||||||||||||||||||||